Divi's Laboratories News
Divi’s Laboratories share price rises 5% a day after Q3 results. Do you own?
Divi’s Laboratories share price gained 5% as the pharma company reported a 64.5% YoY profit increase in Q3 FY25, driven by Custom Synthesis. While Jefferies acknowledges revenue alignment with estimates, concerns about product concentration persist.
1 min read4 Feb 2025Bulk drug makers to benefit from price stability but need to improve efficiency to compete with Chinese rivals: Experts
Falling API prices in India are expected to stabilise, offering some relief to local manufacturers who face competition from lower-priced Chinese products. While prices have dropped, companies must enhance operational efficiency to maintain competitiveness.
4 min read22 Nov 2024CDMO stocks in focus as US House votes on Biosecure Act next week; Divi’s Lab, among others to benefit, says expert
The Biosecure Act may favour Indian CDMOs by limiting US partnerships with specific Chinese firms. Analysts predict a market surge driven by manufacturing cost advantages and increased demand for Indian contracts, marking a pivotal shift in the global CDMO landscape.
3 min read5 Sep 2024Bharti Airtel, BPCL, Hero Moto, JSW Steel and more: 7 Nifty50 stocks that are likely to post over 40% jump in Q3 profit
In the upcoming Q3 results, Motilal Oswal expects Nifty earnings to grow 10% YoY. Overall, earnings growth is likely to be driven again by domestic cyclicals, such as Auto and BFSI. Here’s a list of 7 stocks that may post over 40% jump in their PAT for Q3.
9 Jan 2024Nifty Pharma hits all-time high; 10 stocks including Lupin, Cipla, Glenmark Pharma, Divi’s Labs touch one-year peaks
In today’s trade, Lupin’s shares soared nearly 7%, hitting a new all-time high of ₹1,404 apiece after Japanese brokerage firm Nomura raised the target price on the stock to ₹1,593 apiece from the previous ₹1,290, maintaining its ’buy’ recommendation.
2 min read2 Jan 2024Q1 results today: ITC, Divi’s Labs to Vodafone Idea: 139 companies to declares Q1 results 2023
Q1 results 2023: A total of 139 listed companies are going to declare Q1 results today
2 min read14 Aug 2023Buy or sell: Vaishali Parekh recommends three stocks to buy today — 16th June
Buy or sell stocks: Vaishali Parekh has recommended three stocks to buy today — Finolex Cables, Divi’s Lab and Latent View Analytics
2 min read16 Jun 2023Divi’s Laboratories Q4 results: Share price surges another 4%; Jefferies upgrades to Buy
Divi’s Laboratories posted a consolidated net profit of ₹320.97 crore in Q4FY23, down by 64.1% from ₹894.64 crore in the same quarter a year ago. Sequentially the bottomline rose 2.53%.
1 min read23 May 2023Divi’s Labs recommend 1500% dividend for FY23; how much investors will earn per share?
Divi’s Labs has once again declared an hefty dividend for FY23. In this fiscal, the company will pay its shareholders a dividend per share of ₹30. In percentage terms, the dividend is 1500%.
2 min read20 May 2023Popular Topics
Budget
The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared
Primer
Primer is Mint's signature mode of explaining a complex issue by breaking into five simple questions and answers. We bring you our roster of expert writers across subjects, resulting in explanatory journalism at its very best, published every weekday.